en.unionpedia.org

TiGenix, the Glossary

Index TiGenix

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell (eASC) platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product.[1]

Table of Contents

  1. 12 relations: Belgium, Biotechnology, Crohn's disease, Eduardo Bravo, Euronext, Ghent University, KU Leuven, Leuven, Public company, Research spin-off, Takeda Pharmaceutical Company, The Lancet.

  2. 2000 establishments in Belgium
  3. Biotechnology companies of Belgium
  4. Companies based in Leuven
  5. Pharmaceutical companies disestablished in 2018
  6. Pharmaceutical companies established in 2000

Belgium

Belgium, officially the Kingdom of Belgium, is a country in Northwestern Europe.

See TiGenix and Belgium

Biotechnology

Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services.

See TiGenix and Biotechnology

Crohn's disease

Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any segment of the gastrointestinal tract.

See TiGenix and Crohn's disease

Eduardo Bravo

Eduardo Bravo Ávila (born 18 February 1991) is a Mexican professional footballer who plays as a goalkeeper.

See TiGenix and Eduardo Bravo

Euronext

Euronext N.V. (short for European New Exchange Technology) is a pan-European bourse that provides trading and post-trade services for a range of financial instruments.

See TiGenix and Euronext

Ghent University

Ghent University (Universiteit Gent, abbreviated as UGent) is a public research university located in Ghent, Belgium.

See TiGenix and Ghent University

KU Leuven

KU Leuven (Katholieke Universiteit Leuven) is a Catholic research university in the city of Leuven, Belgium.

See TiGenix and KU Leuven

Leuven

Leuven, also called Louvain (Löwen), is the capital and largest city of the province of Flemish Brabant in the Flemish Region of Belgium.

See TiGenix and Leuven

Public company

A public company is a company whose ownership is organized via shares of stock which are intended to be freely traded on a stock exchange or in over-the-counter markets.

See TiGenix and Public company

Research spin-off

A research spin-off is a company that falls into at least one of the four following categories.

See TiGenix and Research spin-off

Takeda Pharmaceutical Company

The is a Japanese multinational pharmaceutical company.

See TiGenix and Takeda Pharmaceutical Company

The Lancet

The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind.

See TiGenix and The Lancet

See also

2000 establishments in Belgium

Biotechnology companies of Belgium

Companies based in Leuven

Pharmaceutical companies disestablished in 2018

Pharmaceutical companies established in 2000

References

[1] https://en.wikipedia.org/wiki/TiGenix